The Underlying Pharmacological Mechanisms and Active Components of XZZTP in Modulating Bacterial Inflammation Elucidated by LC-MS/MS, Network Pharmacology, In Vitro Experiments, Molecular Docking, and Dynamics Simulations.

Pharmaceuticals (Basel) · 2026 · PMC13210147 · PMID 42198352

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

At 200 μg/mL, treatment with XZZTP resulted in inhibition rates of NO, TNF-α, and PGE2 in RAW 264.7 macrophages of 56.53% ( p < 0.05), 53.75% ( p < 0.01), and 48.49% ( p < 0.01), indicating a highly significant difference compared with the model group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.